Head and Neck Cancer Prevention by Phytochemicals: Current Status and Challenges
- PDF / 856,395 Bytes
- 18 Pages / 595.276 x 790.866 pts Page_size
- 110 Downloads / 184 Views
CANCER CHEMOPREVENTION (R AGARWAL, CV RAO AND S YU, SECTION EDITORS)
Head and Neck Cancer Prevention by Phytochemicals: Current Status and Challenges Vaishnavi K. Nimbalkar 1,2 & Subhakankha Manna 1 & Girish B. Maru 1 & Manoj B. Mahimkar 1,2
# Springer Nature Switzerland AG 2020
Abstract Cancer is a growing health concern worldwide associated with a rise in life expectancy, lifestyle, and environmental exposures. In India, head and neck squamous cell carcinomas (HNSCC) are most common cancers in males and sixth most common cancers worldwide. HNSCC are causally associated with use of tobacco, areca nut, consumption of alcohol, and human papilloma virus (HPV) infection. Primary prevention by minimizing exposure to known carcinogens is promising, but limited success is achieved due to addiction, economic, and individual freedom-related issues. Advancements in treatments of HNSCC have not improved 5-year survival rate beyond 50% in the last two decades. HNSCC development is a multifactorial, multistep process encompassing modifiable initiation, promotion, and progression events. Several plant-derived phytochemicals prevent/delay the onset and decrease incidence and/or multiplicity of carcinogen-induced tumors in HNSCC experimental models. Experimentally proven chemopreventive agents were tested in clinical trials, and only a few of them showed promising results. Important issues for disparity of results between preclinical studies and clinical trials are failure to mimic human conditions in animal models with respect to carcinogen exposure complexities, tissue(s) systems, exposure of normal vs. damaged tissue/DNA to potential chemopreventive agents, bioavailability, toxicity, and mechanistic aspects. This review discusses the progress of phytochemical(s)-mediated chemoprevention in preclinical settings along with completed clinical trials of HNSCC and suggestions for effectively addressing issues related to mismatch. Combining phytochemical(s)-mediated chemoprevention with primary prevention strategies and/or current treatment strategies may provide a better outcome. Keywords HNSCC . Animal models . Phytochemicals . Chemoprevention . Cancer stem cells
Highlights • Phytochemicals showed protective effects in preclinical studies by decreasing incidence and multiplicity and increasing latency period. • Leukoplakia lesions regressed upon treatment with phytochemicals. • Expression of CSC markers was decreased upon treatment with phytochemicals in preclinical studies. • No chemopreventive agent makes tobacco use safe. This article is part of the Topical Collection on Cancer Chemoprevention Electronic supplementary material The online version of this article (https://doi.org/10.1007/s40495-020-00213-w) contains supplementary material, which is available to authorized users. * Girish B. Maru [email protected] * Manoj B. Mahimkar [email protected]; [email protected] 1
Mahimkar Lab, Cancer Research Institute, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre (TMC)
Data Loading...
